Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes

American Journal of Human Genetics

Volumn 72, Issue 3, 2003, Pages 636-649

  Yang, Quanhe ^a,d   Khoury, Muin J ^b   Botto, Lorenzo ^a   Friedman, J M ^d   Flanders, W Dana ^c  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTHROMBIN;

ARTICLE; ENVIRONMENTAL FACTOR; GENETIC DISORDER; GENETIC PROCEDURES; HUMAN; LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN DEFECT; RISK FACTOR; VEIN THROMBOSIS;

EID: 0037370188     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/367923     Document Type: Article

References (31)

1. Albert A (1982) On the use and computation of likelihood ratios in clinical chemistry. Clin Chem 28:1113-1119
2. Barber JC (1998) Code of practice and guidance on human genetic testing services supplied direct to the public. Advisory Committee on Genetic Testing. J Med Genet 35:443-445
3. Beaudet AL (1999) 1998 ASHG presidential address: making genomic medicine a reality. Am J Hum Genet 64:1-13
4. Bell J (1998) The new genetics in clinical practice. BMJ 316:618-620
5. Botto LD, Khoury MJ (2001) Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 153:1016-1020
6. Breslow NE, Day NE, Davis W, Estève J, International Agency for Research on Cancer (1980) Statistical methods in cancer research. IARC Press, Lyon, France
7. Collins FS (1999) Shattuck lecture - medical and societal consequences of the Human Genome Project. N Engl J Med 341:28-37
8. Coughlin SS, Trock B, Criqui MH, Pickle LW, Browner D, Tefft MC (1992) The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test. J Clin Epidemiol 45:1-7
9. Evans JP, Skrzynia C, Burke W (2001) The complexities of predictive genetic testing. BMJ 322:1052-1056
10. Fagan TJ (1975) Letter: nomogram for Bayes theorem. N Engl J Med 293:257
11. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886
12. Greenland S (1983) Tests for interaction in epidemiologic studies: a review and a study of power. Stat Med 2:243-251
13. Guttmacher AE, Collins FS (2002) Genomic medicine: a primer. N Engl J Med 347:1512-1520
14. Hansson PO, Welin L, Tibblin G, Eriksson H (1997) Deep vein thrombosis and pulmonary embolism in the general population. "The Study of Men Born in 1913." Arch Intern Med 157:1665-1670
15. Holtzman NA, Marteau TM (2000) Will genetics revolutionize medicine? N Engl J Med 343:141-144
16. Holtzman NA, Murphy PD, Watson MS, Barr PA (1997) Predictive genetic testing: from basic research to clinical practice. Science 278:602-605
17. Holtzman NA, Watson MS (eds) (1998) Promoting safe and effective genetic testing in the United States: final report of the task force on genetic testing. Johns Hopkins University Press, Baltimore
18. Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3:452-456
19. Kleinbaum DG (1998) Applied regression analysis and other multivariable methods. Duxbury Press, Pacific Grove, CA
20. McCullagh P, Nelder JA (1989) Generalized linear models. Chapman and Hall, London
21. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 232:155-160
22. Pennisi E (1999) DNA chips give new view of classic test. Science 283:17-18
23. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33-36
24. Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH (1997) Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 126:528-531
25. Sackett DL (1991) Clinical epidemiology: a basic science for clinical medicine. Little Brown, Boston
26. Seligsohn U, Lubetsky A (2001) Genetic susceptibility to venous thrombosis. N Engl J Med 344:1222-1231
27. Simel DL, Samsa GP, Matchar DB (1993) Likelihood ratios for continuous test results: making the clinicians' job easier or harder? J Clin Epidemiol 46:85-93
28. Southern EM (1996) DNA chips: analysing sequence by hybridization to oligonucleotides on a large scale. Trends Genet 12:110-115
29. Vineis P, Schulte P, McMichael AJ (2001) Misconceptions about the use of genetic tests in populations. Lancet 357:709-712
30. Wald NJ, Leck I (2000) Antenatal and neonatal screening. Oxford University Press, New York
31. White RH, Zhou H, Romano PS (1998) Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 128:737-740